Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vascular Surgery

  Free Subscription


25.10.2021

4 Am J Cardiol
98 Catheter Cardiovasc Interv
1 Chest
6 Circ Cardiovasc Interv
7 Circ Cardiovasc Qual Outcomes
2 Eur Heart J
11 Eur J Cardiothorac Surg
1 J Am Coll Cardiol
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. ELKARYONI A, Drummond AP, Elgendy IY, Bontu S, et al
    ST-Elevation Myocardial Infarction Transferred from Non-acute Care Hospitals (from a Nationwide Cohort Sample).
    Am J Cardiol. 2021 Aug 14. pii: S0002-9149(21)00711.
    PubMed        

  2. LUSTOSA RP, Fortuni F, van der Bijl P, Mahdiui ME, et al
    Changes in Global Left Ventricular Myocardial Work Indices and Stunning Detection 3 Months After ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2021 Aug 6. pii: S0002-9149(21)00670.
    PubMed         Abstract available

  3. LATIF A, Ahsan MJ, Mirza MM, Aurit S, et al
    Meta-Analysis of Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.
    Am J Cardiol. 2021 Aug 10. pii: S0002-9149(21)00676.
    PubMed         Abstract available

  4. SHARMA H, Radhakrishnan A, Nightingale P, Brown S, et al
    Mitral Regurgitation Following Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention-Prevalence, Risk factors, and Predictors of Outcome.
    Am J Cardiol. 2021 Aug 17. pii: S0002-9149(21)00688.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  5. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    PubMed         Abstract available

  6. AZZALINI L, Carlino M
    A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry.
    Catheter Cardiovasc Interv. 2021;98:E85-E90.
    PubMed         Abstract available

  7. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    PubMed         Abstract available

  8. MEMON S, George JC, Kalra S, Janzer S, et al
    Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent.
    Catheter Cardiovasc Interv. 2021;98:743-747.
    PubMed         Abstract available

  9. KABIR R, Vuppala S, Liu Y, Tejani I, et al
    Clinical outcomes of patients with and without chronic kidney disease undergoing endovascular revascularization of infrainguinal peripheral artery disease: Insights from the XLPAD registry.
    Catheter Cardiovasc Interv. 2021;98:310-316.
    PubMed         Abstract available

  10. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    PubMed         Abstract available

  11. HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
    Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
    Catheter Cardiovasc Interv. 2021;98:411-412.
    PubMed        

  12. JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
    What have we learnt from the use of papyrus covered stent in France and Spain?
    Catheter Cardiovasc Interv. 2021;98:410.
    PubMed        

  13. MCKENZIE A, Zhou C, Svendsen C, Anketell R, et al
    Ability of a novel shock index that incorporates invasive hemodynamics to predict mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Jan 9. doi: 10.1002/ccd.29460.
    PubMed         Abstract available

  14. WATANABE Y, Mitomo S, Naganuma T, Takagi K, et al
    Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry.
    Catheter Cardiovasc Interv. 2021;98:E24-E34.
    PubMed         Abstract available

  15. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    PubMed         Abstract available

  16. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    PubMed         Abstract available

  17. KINNAIRD T, Anderson R, Gallagher S, Sharp ASP, et al
    Vascular complications associated with intraaortic balloon pump supported percutaneous coronary intervention (PCI) and clinical outcomes from the British Cardiovascular Intervention Society National PCI Database.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29549.
    PubMed         Abstract available

  18. ALEJANDRO GB, Gheorghe LL, Camacho Freire S, Silva E, et al
    Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29557.
    PubMed         Abstract available

  19. WANG H, Wang HY, Yin D, Feng L, et al
    Early radial artery occlusion following the use of a transradial 7-French sheath for complex coronary interventions in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29653.
    PubMed         Abstract available

  20. PLOUMEN EH, Buiten RA, Zocca P, Doggen CJM, et al
    Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29594.
    PubMed         Abstract available

  21. GAO L, Gao Z, Song Y, Guan C, et al
    Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29586.
    PubMed         Abstract available

  22. SULIMOV DS, Markuske M, Desch S, Thiele H, et al
    Management of dead space thrombosis during decannulation of peripherally inserted venoarterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2021;98:E122-E123.
    PubMed         Abstract available

  23. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    PubMed         Abstract available

  24. PATHAN AZ, Aijaz S, Sheikh S, Sattar S, et al
    Randomized trial comparing radial hemostasis techniques; catechol conjugated chitosan pad (InnoSEAL) versus pneumatic compression band.
    Catheter Cardiovasc Interv. 2021;98:E181-E187.
    PubMed         Abstract available

  25. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    PubMed         Abstract available

  26. LI X, Qiu M, Na K, Li Y, et al
    Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1032-1039.
    PubMed         Abstract available

  27. ZHANG J, Qiu M, Na K, Ma S, et al
    Impact of 6- versus 12-month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1025-1031.
    PubMed         Abstract available

  28. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    PubMed         Abstract available

  29. TAO L, Li Z, Yin Z, Lin W, et al
    Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Feb 19. doi: 10.1002/ccd.29553.
    PubMed         Abstract available

  30. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    PubMed         Abstract available

  31. RAMASAMY A, Bajaj R, Jones DA, Amersey R, et al
    Iatrogenic catheter-induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10 years.
    Catheter Cardiovasc Interv. 2021;98:649-655.
    PubMed         Abstract available

  32. LHERMUSIER T, Carrie D, Cayla G, Fajadet J, et al
    Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:511-519.
    PubMed         Abstract available

  33. MIDULLA M, Chevallier O, Comby PO, Giordano G, et al
    Endovascular management of the deep venous thrombosis: A new challenging role for the endovascular specialist in 2020.
    Catheter Cardiovasc Interv. 2021;98:748-755.
    PubMed         Abstract available

  34. LEE JH, Kim U, Kim JS, Hong SJ, et al
    Clinical implication of neointimal burden in in-stent restenosis treated with drug-coated balloon.
    Catheter Cardiovasc Interv. 2021;98:493-502.
    PubMed         Abstract available

  35. SHAH R, Labroo A, Davis DA, Le FK, et al
    Increased risk of stent thrombosis with use of a direct oral anticoagulant and a single antiplatelet agent after PCI: A meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:E490-E492.
    PubMed        

  36. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    PubMed         Abstract available

  37. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:197-205.
    PubMed         Abstract available

  38. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2021;98:617-625.
    PubMed         Abstract available

  39. JANG WJ, Chun WJ, Park IH, Choi KH, et al
    Impact of stent designs of second-generation drug-eluting stents on long-term outcomes in coronary bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;98:458-467.
    PubMed         Abstract available

  40. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2021;98:12-21.
    PubMed         Abstract available

  41. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:E324.
    PubMed        

  42. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    PubMed         Abstract available

  43. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    PubMed         Abstract available

  44. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2021;98:45-54.
    PubMed         Abstract available

  45. DUNN AN, Huded C, Simpfendorfer C, Raymond R, et al
    End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
    Catheter Cardiovasc Interv. 2021;98:246-254.
    PubMed         Abstract available

  46. SANZ SANCHEZ J, Garbo R, Gagnor A, Oreglia J, et al
    Management and outcomes of coronary artery perforations treated with the block and deliver technique.
    Catheter Cardiovasc Interv. 2021;98:238-245.
    PubMed         Abstract available

  47. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    PubMed         Abstract available

  48. YAGER N, Schulman-Marcus J, Torosoff M
    Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:436-444.
    PubMed         Abstract available

  49. KERKMEIJER LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, et al
    Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
    Catheter Cardiovasc Interv. 2021;98:713-720.
    PubMed         Abstract available

  50. SAPONTIS J, Hirai T, Patterson C, Gans B, et al
    Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) stud
    Catheter Cardiovasc Interv. 2021;98:626-635.
    PubMed         Abstract available

  51. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    PubMed         Abstract available

  52. KERKMEIJER LSM, Chandrasekhar J, Kalkman DN, Woudstra P, et al
    Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Catheter Cardiovasc Interv. 2021;98:503-510.
    PubMed         Abstract available

  53. MASDJEDI K, van Zandvoort LJ, Balbi MM, Nuis RJ, et al
    Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting.
    Catheter Cardiovasc Interv. 2020 Oct 6. doi: 10.1002/ccd.29311.
    PubMed         Abstract available

  54. PAJJURU VS, Thandra A, Guddeti RR, Kothapalli SR, et al
    ST-elevation myocardial infarction in nonagenarians: A nationwide analysis of trends and outcomes in the United States.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29313.
    PubMed         Abstract available

  55. LUNARDI M, Franzese I, Faggian G, Ribichini FL, et al
    Hybrid treatment of aortic aneurism, type-A dissection, and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Sep 26. doi: 10.1002/ccd.29303.
    PubMed         Abstract available

  56. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    PubMed         Abstract available

  57. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    PubMed         Abstract available

  58. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    PubMed         Abstract available

  59. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    PubMed         Abstract available

  60. OTSUKA T, Ueki Y, Kavaliauskaite R, Zanchin T, et al
    Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29650.
    PubMed         Abstract available

  61. COBB H, Spray B, Daily J, Dossey A, et al
    Cutting balloon angioplasty on branch pulmonary artery stenosis in pediatric patients.
    Catheter Cardiovasc Interv. 2021;98:526-532.
    PubMed         Abstract available

  62. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    PubMed         Abstract available

  63. KOH JS, Gogas BD, Kumar S, Benham JJ, et al
    Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;98:723-732.
    PubMed         Abstract available

  64. ZGHOUZI M, Moussa Pacha H, Ullah W, Sattar Y, et al
    In-hospital outcomes of endovascular versus surgical revascularization for chronic total occlusion in peripheral artery disease.
    Catheter Cardiovasc Interv. 2021;98:E586-E593.
    PubMed         Abstract available

  65. BOEDER NF, Kastner J, Mehilli J, Munzel T, et al
    Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.
    Catheter Cardiovasc Interv. 2021;98:E555-E563.
    PubMed         Abstract available

  66. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    PubMed         Abstract available

  67. TROBS M, Achenbach S, Nef HM, Gori T, et al
    Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:E564-E570.
    PubMed         Abstract available

  68. ROCHA-SINGH KJ, Sachar R, DeRubertis BG, Nolte-Ernsting CCA, et al
    Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Catheter Cardiovasc Interv. 2021;98:549-558.
    PubMed         Abstract available

  69. SALAHUDDIN T, Giannopoulos S, Adams G, Armstrong EJ, et al
    Anterior, posterior, or all-vessel infrapopliteal revascularization in patients with moderate-severe claudication: Insights from the LIBERTY 360 study.
    Catheter Cardiovasc Interv. 2021;98:559-569.
    PubMed         Abstract available

  70. DAI Y, Ge J
    The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
    Catheter Cardiovasc Interv. 2021;98:43-44.
    PubMed        

  71. SHROFF GR, Henry TD
    Percutaneous coronary intervention in end-stage kidney disease: Trapped between a rock and a hard place.
    Catheter Cardiovasc Interv. 2021;98:215-216.
    PubMed        

  72. WINSCOTT JG, Hillegass WB
    Critical limb ischemia in the end stage renal disease patient: Some next steps.
    Catheter Cardiovasc Interv. 2021;98:308-309.
    PubMed        

  73. HAWAMDEH H, Moliterno DJ
    Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;98:689-690.
    PubMed         Abstract available

  74. KERN MJ
    Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
    Catheter Cardiovasc Interv. 2021;98:669-670.
    PubMed        

  75. TARANTINI G, Zuccarelli V
    Percutaneous coronary intervention versus coronary artery bypass graft surgery: The battle rages on.
    Catheter Cardiovasc Interv. 2021;98:434-435.
    PubMed        

  76. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    PubMed        

  77. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    PubMed        

  78. STABILE E, Esposito G
    Below the knee percutaneous transluminal angioplasty for claudicants: One vessel is enough to relieve symptoms.
    Catheter Cardiovasc Interv. 2021;98:570-571.
    PubMed         Abstract available

  79. POSTALIAN A, Krajcer Z
    MANTA versus Perclose for large-bore vessel closure: The evidence continues to grow.
    Catheter Cardiovasc Interv. 2021;98:586-587.
    PubMed         Abstract available

  80. CAO D, Dangas GD
    Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better.
    Catheter Cardiovasc Interv. 2021;98:206-207.
    PubMed        

  81. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    PubMed         Abstract available

  82. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    PubMed         Abstract available

  83. CORDERO A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, et al
    Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
    Catheter Cardiovasc Interv. 2021;98:E342-E350.
    PubMed         Abstract available

  84. DAWSON DB, Telles-Garcia NA, Atkins JL, Mina GS, et al
    End-stage renal disease patients undergoing angioplasty and bypass for critical limb ischemia have worse outcomes compared to non-ESRD patients: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:297-307.
    PubMed         Abstract available

  85. ICHIHASHI S, Tamura Y, Maeda S, Kichikawa K, et al
    Percutaneous deep venous arterialization at femoropopliteal segment for unhealed amputated stump ulcer after below the knee amputation.
    Catheter Cardiovasc Interv. 2021;98:E124-E126.
    PubMed         Abstract available

  86. KIM M, Park KW, Lee HS, Ki YJ, et al
    The validation of the dual antiplatelet therapy score in East Asians receiving percutaneous coronary intervention with exclusively second generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29682.
    PubMed         Abstract available

  87. ZHAO Y, Li J, Ma S, Jiang Z, et al
    Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2021;98:E235-E242.
    PubMed         Abstract available

  88. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    PubMed         Abstract available

  89. LIU ZY, Yin ZH, Liang CY, He J, et al
    Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29655.
    PubMed         Abstract available

  90. HU X, Qiao S, Guan C, Guo C, et al
    Angiographic characteristics and long-term outcomes of single-vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29651.
    PubMed         Abstract available

  91. SHAH AM, Siddiqui E, Cuenca C, Drotar P, et al
    Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29649.
    PubMed         Abstract available

  92. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    PubMed         Abstract available

  93. MOCCETTI F, Wolfrum M, Bossard M, Attinger-Toller A, et al
    Reduction of MANTA-associated vascular complications after implementation of key insights on failure mechanisms.
    Catheter Cardiovasc Interv. 2021;98:E462-E465.
    PubMed         Abstract available

  94. OBA Y, Inohara T, Takahashi M, Fukutomi M, et al
    In-hospital outcomes and usage of embolic protection devices in percutaneous coronary intervention for coronary artery bypass grafts: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2021 Apr 16. doi: 10.1002/ccd.29695.
    PubMed         Abstract available

  95. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    PubMed         Abstract available

  96. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    PubMed         Abstract available

  97. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    PubMed         Abstract available

  98. YELAVARTHY P, Seth M, Pielsticker E, Grines CL, et al
    The DISCO study-Does Interventionalists' Sex impact Coronary Outcomes?
    Catheter Cardiovasc Interv. 2021;98:E531-E539.
    PubMed         Abstract available

  99. ONO M, Kawashima H, Hara H, Gamal A, et al
    External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2021;98:E513-E522.
    PubMed         Abstract available

  100. KATSUKI T, Yamaji K, Soga Y, Iida O, et al
    New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication.
    Catheter Cardiovasc Interv. 2021;98:E395-E402.
    PubMed         Abstract available

  101. O'NEILL BP, Grines C, Moses JW, Ohman EM, et al
    Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29758.
    PubMed         Abstract available

  102. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    PubMed         Abstract available


    Chest

  103. BARROS AJ, Enfield KB, Kadl A
    Intraarterial Catheter Use Is Associated With Increased Risk of Hospital Onset Bacteremia: A Retrospective Cohort Study.
    Chest. 2021;159:2321-2324.
    PubMed        


    Circ Cardiovasc Interv

  104. SHAH M, Najam O, Bhindi R, De Silva K, et al
    Calcium Modification Techniques in Complex Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2021 Jan 14:CIRCINTERVENTIONS120009870.
    PubMed         Abstract available

  105. KI YJ, Kang J, Yang HM, Woo Park K, et al
    Immediate Compared With Delayed Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction Presenting >/=12 Hours After Symptom Onset Is Not Associated With Improved Clinical Outcome.
    Circ Cardiovasc Interv. 2021;14:e009863.
    PubMed         Abstract available

  106. COLE J, Htun N, Lew R, Freilich M, et al
    Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
    Circ Cardiovasc Interv. 2021;14:e009992.
    PubMed         Abstract available

  107. FERRONE M, Chieffo A, Khawaja SA, Moncada M, et al
    RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results.
    Circ Cardiovasc Interv. 2021;14:e010013.
    PubMed        

  108. YAMAMOTO K, Watanabe H, Morimoto T, Domei T, et al
    Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 Trial.
    Circ Cardiovasc Interv. 2021;14:e010384.
    PubMed         Abstract available

  109. CLAASSENS DMF, Bergmeijer TO, Vos GJA, Hermanides RS, et al
    Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis.
    Circ Cardiovasc Interv. 2021 Mar 16:CIRCINTERVENTIONS120009434.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  110. HOLLINGSWORTH JM, Yu X, Yan PL, Yoo H, et al
    Provider Care Team Segregation and Operative Mortality Following Coronary Artery Bypass Grafting.
    Circ Cardiovasc Qual Outcomes. 2021 Apr 30:CIRCOUTCOMES120007778.
    PubMed         Abstract available

  111. MORI M, Durant TJS, Huang C, Mortazavi BJ, et al
    Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient Boosting.
    Circ Cardiovasc Qual Outcomes. 2021 Jun 3:CIRCOUTCOMES120007363.
    PubMed         Abstract available

  112. DAYOUB EJ, Nathan AS, Khatana SAM, Wadhera RK, et al
    Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria.
    Circ Cardiovasc Qual Outcomes. 2021 Mar 15:CIRCOUTCOMES120006887.
    PubMed         Abstract available

  113. THUESEN AL, Riber LP, Veien KT, Christiansen EH, et al
    Health-Related Quality of Life and Angina in Fractional Flow Reserve- Versus Angiography-Guided Coronary Artery Bypass Grafting: From the Randomized Fractional Flow Reserve- Versus Angiography-Guided Coronary Artery Bypass Grafting.
    Circ Cardiovasc Qual Outcomes. 2021 Jun 3:CIRCOUTCOMES120007302.
    PubMed         Abstract available

  114. ZHOU J, Liew D, Duffy SJ, Shaw J, et al
    Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis.
    Circ Cardiovasc Qual Outcomes. 2021;14:e006789.
    PubMed         Abstract available

  115. SCHLEMM L, Endres M, Nolte CH
    Cost Effectiveness of Interhospital Transfer for Mechanical Thrombectomy of Acute Large Vessel Occlusion Stroke: Role of Predicted Recanalization Rates.
    Circ Cardiovasc Qual Outcomes. 2021 Apr 5:CIRCOUTCOMES120007444.
    PubMed         Abstract available

  116. LI X, Gu D, Wang X, Diao X, et al
    Trends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 2018.
    Circ Cardiovasc Qual Outcomes. 2021 Apr 5:CIRCOUTCOMES120007025.
    PubMed         Abstract available


    Eur Heart J

  117. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed         Abstract available

  118. CORTESE F, Magli M, Di Marino S
    A floating thrombus in the ascending aorta, as a complication of a percutaneous coronary angiography.
    Eur Heart J. 2020 Dec 14. pii: 6034852. doi: 10.1093/eurheartj/ehaa1001.
    PubMed        


    Eur J Cardiothorac Surg

  119. AHMED Y, Nama N, Houben IB, van Herwaarden JA, et al
    Imaging surveillance after open aortic repair: a feasibility study of three-dimensional growth mapping.
    Eur J Cardiothorac Surg. 2021;60:651-659.
    PubMed         Abstract available

  120. BECKMANN E, Martens A, Kruger H, Korte W, et al
    Aortic valve-sparing root replacement with Tirone E. David's reimplantation technique: single-centre 25-year experience.
    Eur J Cardiothorac Surg. 2021 Mar 29. pii: 6199187. doi: 10.1093.
    PubMed         Abstract available

  121. HAGE F, Hage A, Dagenais F, Cartier A, et al
    Does adding an aortic root replacement or sinus repair during arch repair increase postoperative mortality? Evidence from the Canadian Thoracic Aortic Collaborative.
    Eur J Cardiothorac Surg. 2021;60:623-630.
    PubMed         Abstract available

  122. JUNG JC, Sohn B, Chang HW, Lee JH, et al
    Diameter change in completely remodelled proximal descending aorta after acute type I dissection repair: implications for estimating the pre-dissection size.
    Eur J Cardiothorac Surg. 2021;60:614-621.
    PubMed         Abstract available

  123. RUSTUM S, Beckmann E, Martens A, Kruger H, et al
    Native and prosthetic graft infections of the thoracic aorta: surgical management.
    Eur J Cardiothorac Surg. 2021;60:633-641.
    PubMed         Abstract available

  124. SA MPBO, Cavalcanti LRP, Rayol SC, Diniz R, et al
    Cardiac tamponade during contrast infusion through central venous catheter.
    Eur J Cardiothorac Surg. 2021;60:722.
    PubMed        

  125. TRIMARCHI S, Bissacco D, Lomazzi C, Domanin M, et al
    The best in the whole.
    Eur J Cardiothorac Surg. 2021;60:660-661.
    PubMed        

  126. CZERNY M, Berger T, Kondov S, Siepe M, et al
    Results of endovascular aortic arch repair using the Relay Branch system.
    Eur J Cardiothorac Surg. 2021;60:662-668.
    PubMed         Abstract available

  127. SIEMENI T, Farber G, Doenst T
    Treatment effects of coronary bypass surgery-the math and the myths of the ejection fraction.
    Eur J Cardiothorac Surg. 2021;60:697-698.
    PubMed        

  128. HEUTS S, Sardari Nia P
    Periprocedural myocardial infarction: a web of definitions.
    Eur J Cardiothorac Surg. 2021;60:443-447.
    PubMed        

  129. GASPARINI M, Cox N
    Role of cardiac magnetic resonance strain analysis in patients with hypoplastic left heart syndrome in evaluating right ventricular (dys)function: a systematic review.
    Eur J Cardiothorac Surg. 2021;60:497-505.
    PubMed         Abstract available


    J Am Coll Cardiol

  130. YAMMINE H, Briggs CS, Rolle QV, Ballast JK, et al
    Simultaneous Transcatheter Aortic Valve Replacement and Endovascular Aortic Aneurysm Repair.
    J Am Coll Cardiol. 2021;77:2156-2157.
    PubMed        


    PLoS One

  131. SONG MY, Noh SR, Kim KY
    Refractive prediction of four different intraocular lens calculation formulas compared between new swept source optical coherence tomography and partial coherence interferometry.
    PLoS One. 2021;16:e0251152.
    PubMed         Abstract available

  132. MURAOKA S, Somiya D, Ebata A, Kumagai Y, et al
    Future stroke risk in the chronic phase of post-percutaneous coronary intervention.
    PLoS One. 2021;16:e0251253.
    PubMed         Abstract available

  133. KIM SY, Kim KN, Jeong MA, Lee BS, et al
    Ultrasound-guided dynamic needle tip positioning technique for radial artery cannulation in elderly patients: A prospective randomized controlled study.
    PLoS One. 2021;16:e0251712.
    PubMed         Abstract available

  134. CHOI BG, Hong JY, Rha SW, Choi CU, et al
    Long-term outcomes of peripheral arterial disease patients with significant coronary artery disease undergoing percutaneous coronary intervention.
    PLoS One. 2021;16:e0251542.
    PubMed         Abstract available

  135. BONKAIN F, Stolear JC, Catalano C, Vandervelde D, et al
    Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial.
    PLoS One. 2021;16:e0251793.
    PubMed         Abstract available

  136. YANASE T, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Factors associated with temporary pacing insertion in patients with inferior ST-segment elevation myocardial infarction.
    PLoS One. 2021;16:e0251124.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: